Genomic Classification and Individualized Prognosis in Multiple Myeloma

Abstract

Integrating clinical, demographic, genomic, and therapeutic data, to our knowledge, we have developed the first individualized risk-prediction model enabling personally tailored therapeutic decisions for patients with NDMM.